Adagio Therapeutics Inc

NASDAQ:ADGI   3:59:55 PM EDT
55.00
+5.63 (+11.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Adagio Therapeutics Inc Stock, NASDAQ:ADGI

303 Wyman Street, Suite 300, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.819.0080
Number of Employees: 49

Description

Adagio Therapeutics, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren? Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.